Inter-cellular adhesion disruption and the RAS/RAF and beta-catenin signalling in lung cancer progression

Cancer Cell International

Volumn 8, Issue , 2008, Pages

  Götz, Rudolf ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE; RAF PROTEIN; RAS PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN; WNT PROTEIN;

CANCER GROWTH; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; EPIGENETICS; EPITHELIUM CELL; GENE EXPRESSION; GENE MUTATION; HUMAN; LUNG ADENOCARCINOMA; LUNG ADENOMA; LUNG CANCER; LUNG CARCINOGENESIS; LUNG DYSPLASIA; LUNG NON SMALL CELL CANCER; MICROMETASTASIS; NONHUMAN; ONCOGENE; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 45749115401     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-8-8     Document Type: Review

References (151)

1. Jemal A Siegel R Ward E Murray T Xu J Smigal C Thun MJ Cancer statistics, 2006 CA Cancer J Clin 2006, 56:106-130. 16514137
2. Merrill RM Weed DL Measuring the public health burden of cancer in the United States through lifetime and age-conditional risk estimates Ann Epidemiol 2001, 11:547-553. 10.1016/S1047-2797(01)00254-X 11709274
3. Alberg AJ Ford JG Samet JM Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition) Chest 2007, 132:29S-55S. 10.1378/chest.07-1347 17873159
4. Sun S Schiller JH Gazdar AF Lung cancer in never smokers - a different disease Nat Rev Cancer 2007, 7:778-790. 10.1038/nrc2190 17882278
5. Beckles MA Spiro SG Colice GL Rudd RM Initial evaluation of the patient with lung cancer: Symptoms, signs, laboratory tests, and paraneoplastic syndromes Chest 2003, 123:97S-104S. 10.1378/chest.123.1_suppl.97S 12527569
6. Flieder DB Vazquez M Carter D Brambilla E Gazdar A Noguchi M Travis WD Kramer A Yankelevitz DF Henschke CI Pathologic findings of lung tumors diagnosed on baseline CT screening Am J Surg Pathol 2006, 30:606-613. 10.1097/01.pas.0000202040.51967.d0 16699315
7. Futreal PA Coin L Marshall M Down T Hubbard T Wooster R Rahman N Stratton MR A census of human cancer genes Nat Rev Cancer 2004, 4:177-183. 10.1038/nrc1299 14993899
8. Weir BA Woo MS Getz G Perner S Ding L Beroukhim R Lin WM Province MA Kraja A Johnson LA Shah K Sato M Thomas RK Barletta JA Borecki IB Broderick S Chang AC Chiang DY Chirieac LR Cho J Fujii Y Gazdar AF Giordano T Greulich H Hanna M Johnson BE Kris MG Lash A Lin L Lindeman N Mardis ER McPherson JD Minna JD Morgan MB Nadel M Orringer MB Osborne JR Ozenberger B Ramos AH Robinson J Roth JA Rusch V Sasaki H Shepherd F Sougnez C Spitz MR Tsao MS Twomey D Verhaak RG Weinstock GM Wheeler DA Winckler W Yoshizawa A Yu S Zakowski MF Zhang Q Beer DG Wistuba II Watson MA Garraway LA Ladanyi M Travis WD Pao W Rubin MA Gabriel SB Gibbs RA Varmus HE Wilson RK Lander ES Meyerson M Characterizing the cancer genome in lung adenocarcinoma Nature 2007, 450(7171):893-898. 10.1038/nature06358 17982442
9. Meuwissen R Linn SC van V Mooi WJ Berns A Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene Oncogene 2001, 20:6551-6558. 10.1038/sj.onc.1204837 11641780
10. Wang JC Dick JE Cancer stem cells: Lessons from leukemia Trends Cell Biol 2005, 15:494-501. 10.1016/j.tcb.2005.07.004 16084092
11. Clarke MF Fuller M Stem cells and cancer: Two faces of eve Cell 2006, 124:1111-1115. 10.1016/j.cell.2006.03.011 16564000
12. Cardoso WV Lu J Regulation of early lung morphogenesis: Questions, facts and controversies Development 2006, 133:1611-1624. 10.1242/dev.02310 16613830
13. Blenkinsopp WK Proliferation of respiratory tract epithelium in the rat Exp Cell Res 1967, 46:144-154. 10.1016/0014-4827(67)90416-8 6025276
14. Rawlins EL Hogan BL Epithelial stem cells of the lung: Privileged few or opportunities for many? Development 2006, 133:2455-2465. 10.1242/ dev.02407 16735479
15. Liu X Driskell RR Engelhardt JF Stem cells in the lung Methods Enzymol 2006, 419:285-321. 1803078 17141060 10.1016/S0076-6879(06)19012-6
16. Nogee LM Alterations in SP-B and SP-C expression in neonatal lung disease Annu Rev Physiol 2004, 66:601-623. 10.1146/ annurev.physiol.66.032102.134711 14977415
17. Giangreco A Reynolds SD Stripp BR Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction Am J Pathol 2002, 161:173-182. 1850682 12107102
18. Kim CF Jackson EL Woolfenden AE Lawrence S Babar I Vogel S Crowley D Bronson RT Jacks T Identification of bronchioalveolar stem cells in normal lung and lung cancer Cell 2005, 121:823-835. 10.1016/ j.cell.2005.03.032 15960971
19. Theise ND Henegariu O Grove J Jagirdar J Kao PN Crawford JM Badve S Saxena R Krause DS Radiation pneumonitis in mice: A severe injury model for pneumocyte engraftment from bone marrow Exp Hematol 2002, 30:1333-1338. 10.1016/S0301-472X(02)00931-1 12423687
20. Hay J Shahzeidi S Laurent G Mechanisms of bleomycin-induced lung damage Arch Toxicol 1991, 65:81-94. 10.1007/BF02034932 1711838
21. Kasper M Haroske G Alterations in the alveolar epithelium after injury leading to pulmonary fibrosis Histol Histopathol 1996, 11:463-483. 8861769
22. Zhao X Weir BA LaFramboise T Lin M Beroukhim R Garraway L Beheshti J Lee JC Naoki K Richards WG Sugarbaker D Chen F Rubin MA Janne PA Girard L Minna J Christiani D Li C Sellers WR Meyerson M Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis Cancer Res 2005, 65:5561-5570. 10.1158/0008-5472.CAN-04-4603 15994928
23. Paez JG Janne PA Lee JC Tracy S Greulich H Gabriel S Herman P Kaye FJ Lindeman N Boggon TJ Naoki K Sasaki H Fujii Y Eck MJ Sellers WR Johnson BE Meyerson M EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy Science 2004, 304:1497-1500. 10.1126/ science.1099314 15118125
24. Lynch TJ Bell DW Sordella R Gurubhagavatula S Okimoto RA Brannigan BW Harris PL Haserlat SM Supko JG Haluska FG Louis DN Christiani DC Settleman J Haber DA Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N Engl J Med 2004, 350:2129-2139. 10.1056/NEJMoa040938 15118073
25. Bamford S Dawson E Forbes S Clements J Pettett R Dogan A Flanagan A Teague J Futreal PA Stratton MR Wooster R The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website Br J Cancer 2004, 91:355-358. 15188009
26. Greulich H Chen TH Feng W Janne PA Alvarez JV Zappaterra M Bulmer SE Frank DA Hahn WC Sellers WR Meyerson M Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants PLoS Med 2005, 2:e313. 1240052 16187797 10.1371/journal.pmed.0020313
27. Minami Y Shimamura T Shah K LaFramboise T Glatt KA Liniker E Borgman CL Haringsma HJ Feng W Weir BA Lowell AM Lee JC Wolf J Shapiro GI Wong KK Meyerson M Thomas RK The major lung cancer-derived mutants of ERBB2 are oncogenic and are associated with sensitivity to the irreversible EGFR/ ERBB2 inhibitor HKI-272 Oncogene 2007, 26:5023-5027. 10.1038/ sj.onc.1210292 17311002
28. Stephens P Hunter C Bignell G Edkins S Davies H Teague J Stevens C O'Meara S Smith R Parker A Barthorpe A Blow M Brackenbury L Butler A Clarke O Cole J Dicks E Dike A Drozd A Edwards K Forbes S Foster R Gray K Greenman C Halliday K Hills K Kosmidou V Lugg R Menzies A Perry J Petty R Raine K Ratford L Shepherd R Small A Stephens Y Tofts C Varian J West S Widaa S Yates A Brasseur F Cooper CS Flanagan AM Knowles M Leung SY Louis DN Looijenga LH Malkowicz B Pierotti MA Teh B Chenevix-Trench G Weber BL Yuen ST Harris G Goldstraw P Nicholson AG Futreal PA Wooster R Stratton MR Lung cancer: Intragenic ERBB2 kinase mutations in tumours Nature 2004, 431(7008):525-526. 10.1038/431525b 15457249
29. Tichelaar JW Lu W Whitsett JA Conditional expression of fibroblast growth factor-7 in the developing and mature lung J Biol Chem 2000, 275:11858-11864. 10.1074/jbc.275.16.11858 10766812
30. Ji H Li D Chen L Shimamura T Kobayashi S McNamara K Mahmood U Mitchell A Sun Y Al Hashem R Chirieac LR Padera R Bronson RT Kim W Janne PA Shapiro GI Tenen D Johnson BE Weissleder R Sharpless NE Wong KK The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies Cancer Cell 2006, 9:485-495. 10.1016/j.ccr.2006.04.022 16730237
31. Politi K Zakowski MF Fan PD Schonfeld EA Pao W Varmus HE Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors Genes Dev 2006, 20:1496-1510. 1475762 16705038 10.1101/gad.1417406
32. Repasky GA Chenette EJ Der CJ Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis? Trends Cell Biol 2004, 14:639-647. 10.1016/j.tcb.2004.09.014 15519853
33. Malumbres M Barbacid M RAS oncogenes: The first 30 years Nat Rev Cancer 2003, 3:459-465. 10.1038/nrc1097 12778136
34. Downward J Targeting RAS signalling pathways in cancer therapy Nat Rev Cancer 2003, 3:11-22. 10.1038/nrc969 12509763
35. Guerra C Mijimolle N Dhawahir A Dubus P Barradas M Serrano M Campuzano V Barbacid M Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context Cancer Cell 2003, 4:111-120. 10.1016/ S1535-6108(03)00191-0 12957286
36. Collado M Gil J Efeyan A Guerra C Schuhmacher AJ Barradas M Benguria A Zaballos A Flores JM Barbacid M Beach D Serrano M Tumour biology: senescence in premalignant tumours Nature (London) 2005, 436:642. 10.1038/436642a
37. Sakamoto H Shimizu J Horio Y Ueda R Takahashi T Mitsudomi T Yatabe Y Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas J Pathol 2007, 212:287-294. 10.1002/path.2165 17534846
38. Schreck R Rapp UR Raf kinases: Oncogenesis and drug discovery Int J Cancer 2006, 119:2261-2271. 10.1002/ijc.22144 16894562
39. McKay MM Morrison DK Integrating signals from RTKs to ERK/MAPK Oncogene 2007, 26:3113-3121. 10.1038/sj.onc.1210394 17496910
40. Wellbrock C Karasarides M Marais R The RAF proteins take centre stage Nat Rev Mol Cell Biol 2004, 5:875-885. 10.1038/nrm1498 15520807
41. Davies H Bignell GR Cox C Stephens P Edkins S Clegg S Teague J Woffendin H Garnett MJ Bottomley W Davis N Dicks E Ewing R Floyd Y Gray K Hall S Hawes R Hughes J Kosmidou V Menzies A Mould C Parker A Stevens C Watt S Hooper S Wilson R Jayatilake H Gusterson BA Cooper C Shipley J Hargrave D Pritchard-Jones K Maitland N Chenevix-Trench G Riggins GJ Bigner DD Palmieri G Cossu A Flanagan A Nicholson A Ho JW Leung SY Yuen ST Weber BL Seigler HF Darrow TL Paterson H Marais R Marshall CJ Wooster R Stratton MR Futreal PA Mutations of the BRAF gene in human cancer Nature (London) 2002, 417:949-954. 10.1038/nature00766
42. Lee JW Soung YH Kim SY Park WS Nam SW Min WS Kim SH Lee JY Yoo NJ Lee SH Mutational analysis of the ARAF gene in human cancers APMIS 2005, 113:54-57. 10.1111/j.1600-0463.2005.apm1130108.x 15676015
43. Emuss V Garnett M Mason C Marais R Mutations of C-RAF are rare in human cancer because C-RAF has a low basal kinase activity compared with B-RAF Cancer Res 2005, 65:9719-9726. 10.1158/0008-5472.CAN-05-1683 16266992
44. Rapp UR Huleihel M Pawson A Minna JD Fanning-Heidecker G Cleveland JL Beck T Forchhammer J Storm SM Role of raf oncogenes in lung carcinogenesis J Int Assoc for the Study of Lung Cancer 1988, 4:162-167. 10.1016/S0169-5002(88)80039-4
45. McPhillips F Mullen P MacLeod KG Sewell JM Monia BP Cameron DA Smyth JF Langdon SP Raf-1 is the predominant Raf isoform that mediates growth factor-stimulated growth in ovarian cancer cells Carcinogenesis 2006, 27:729-739. 10.1093/carcin/bgi289 16332724
46. Dankort D Filenova E Collado M Serrano M Jones K McMahon M A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors Genes Dev 2007, 21:379-384. 1804325 17299132 10.1101/gad.1516407
47. Ji H Wang Z Perera SA Li D Liang MC Zaghlul S McNamara K Chen L Albert M Sun Y Al Hashem R Chirieac LR Padera R Bronson RT Thomas RK Garraway LA Janne PA Johnson BE Chin L Wong KK Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models Cancer Res 2007, 67:4933-4939. 10.1158/ 0008-5472.CAN-06-4592 17510423
48. Kerkhoff E Fedorov LM Siefken R Walter AO Papadopoulus T Rapp UR Lung-targeted expression of the c-Raf-1 kinase in transgenic mice exposes a novel oncogenic character of the wild-type protein Cell Growth Diff 2000, 11:185-190. 10775035
49. Bohinski RJ Di Lauro R Whitsett JA The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis Mol Cell Biol 1994, 14:5671-5681. 359092 8065304
50. Kwei KA Kim YH Girard L Kao J Pacyna-Gengelbach M Salari K Lee J Choi YL Sato M Wang P Hernandez-Boussard T Gazdar AF Petersen I Minna JD Pollack JR Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer Oncogene 2008. 18212743
51. Minoo P Su G Drum H Bringas P Kimura S Defects in tracheoesophageal and lung morphogenesis in Nkx2.1(-/-) mouse embryos Dev Biol 1999, 209:60-71. 10.1006/dbio.1999.9234 10208743
52. Wert SE Glasser SW Korfhagen TR Whitsett JA Transcriptional elements from the human SP-C gene direct expression in the primordial respiratory epithelium of transgenic mice Dev Biol 1993, 156:426-443. 10.1006/ dbio.1993.1090 8462742
53. Okubo T Knoepfler PS Eisenman RN Hogan BL Nmyc plays an essential role during lung development as a dosage-sensitive regulator of progenitor cell proliferation and differentiation Development 2005, 132:1363-1374. 10.1242/dev.01678 15716345
54. Ceteci F Ceteci S Karreman C Kramer BW Asan E Götz R Rapp UR Disruption of Tumor Cell Adhesion Promotes Angiogenic Switch and Progression to Micrometastasis in RAF-driven Murine Lung Cancer Cancer Cell 2007, 12(2):145-159. 10.1016/j.ccr.2007.06.014 17692806
55. Fedorov LM Papadopoulos T Tyrsin OY Twardzik T Götz R Rapp UR Bcl-2 determines susceptibility to induction of lung cancer by oncogenic CRaf Cancer Res 2002, 62:6297-6303. 12414660
56. Götz R Kramer BW Camarero G Rapp UR BAG-1 haplo-insufficiency impairs lung tumorigenesis BMC Cancer 2004, 24:85. 10.1186/1471-2407-4-85
57. Fedorov LM Papadopoulos T Tyrsin OY Twardzik T Götz R Rapp UR Loss of p53 in craf induced transgenic lung adenoma leads to tumor acceleration and phenotypic switch Cancer Res 2003, 63:2268-2277. 12727849
58. Suzuki K Nagai K Yoshida J Yokose T Kodama T Takahashi K Nishimura M Kawasaki H Yokozaki M Nishiwaki Y The prognosis of resected lung carcinoma associated with atypical adenomatous hyperplasia: A comparison of the prognosis of well-differentiated adenocarcinoma associated with atypical adenomatous hyperplasia and intrapulmonary metastasis Cancer 1997, 79:1521-1526. 10.1002/ (SICI)1097-0142(19970415)79:8<1521::AID-CNCR12>3.0.CO;2-# 9118033
59. Hawkins PT Anderson KE Davidson K Stephens LR Signalling through Class I PI3Ks in mammalian cells Biochem Soc Trans 2006, 34:647-662. 10.1042/ BST0340647 17052169
60. Manning BD Cantley LC AKT/PKB signaling: Navigating downstream Cell 2007, 129:1261-1274. 10.1016/j.cell.2007.06.009 17604717
61. Lin X Bohle AS Dohrmann P Leuschner I Schulz A Kremer B Fandrich F Overexpression of phosphatidylinositol 3-kinase in human lung cancer Langenbecks Arch Surg 2001, 386:293-301. 10.1007/s004230100203 11466572
62. Brognard J Clark AS Ni Y Dennis PA Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation Cancer Res 2001, 61:3986-3997. 11358816
63. Tang JM He QY Guo RX Chang XJ Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis Lung Cancer 2006, 51:181-191. 10.1016/j.lungcan.2005.10.003 16324768
64. Cully M You H Levine AJ Mak TW Beyond PTEN mutations: The PI3K pathway as an integrator of multiple inputs during tumorigenesis Nat Rev Cancer 2006, 6:184-192. 10.1038/nrc1819 16453012
65. Marsit CJ Zheng S Aldape K Hinds PW Nelson HH Wiencke JK Kelsey KT PTEN expression in non-small-cell lung cancer: Evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration Hum Pathol 2005, 36:768-776. 10.1016/j.humpath.2005.05.006 16084946
66. Gupta S Ramjaun AR Haiko P Wang Y Warne PH Nicke B Nye E Stamp G Alitalo K Downward J Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice Cell 2007, 129:957-968. 10.1016/j.cell.2007.03.051 17540175
67. Takeichi M Morphogenetic roles of classic cadherins Curr Opin Cell Biol 1995, 7:619-627. 10.1016/0955-0674(95)80102-2 8573335
68. Stappert J Kemler R A short core region of E-cadherin is essential for catenin binding and is highly phosphorylated Cell Adhes Commun 1994, 2:319-327. 10.3109/15419069409014207 7820535
69. Chen YT Stewart DB Nelson WJ Coupling assembly of the E-cadherin/ beta-catenin complex to efficient endoplasmic reticulum exit and basal-lateral membrane targeting of E-cadherin in polarized MDCK cells J Cell Biol 1999, 144:687-699. 2132940 10037790 10.1083/jcb.144.4.687
70. Drees F Pokutta S Yamada S Nelson WJ Weis WI Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly Cell 2005, 123:903-915. 10.1016/ j.cell.2005.09.021 16325583
71. Yamada S Pokutta S Drees F Weis WI Nelson WJ Deconstructing the cadherin-catenin-actin complex Cell 2005, 123:889-901. 10.1016/ j.cell.2005.09.020 16325582
72. Kim L Wong TW The cytoplasmic tyrosine kinase FER is associated with the catenin-like substrate pp120 and is activated by growth factors Mol Cell Biol 1995, 15:4553-4561. 230695 7623846
73. Piedra J Miravet S Castano J Palmer HG Heisterkamp N Garcia H Dunach M p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction Mol Cell Biol 2003, 23:2287-2297. 150740 12640114 10.1128/ MCB.23.7.2287-2297.2003
74. Xu G Craig AW Greer P Miller M Anastasiadis PZ Lilien J Balsamo J Continuous association of cadherin with beta-catenin requires the non-receptor tyrosine-kinase Fer J Cell Sci 2004, 117:3207-3219. 10.1242/ jcs.01174 15226396
75. Nelson WJ Nusse R Convergence of Wnt, beta-catenin, and cadherin pathways Science 2004, 303:1483-1487. 10.1126/science.1094291 15001769
76. Price MA CKI, there's more than one: Casein kinase I family members in Wnt and Hedgehog signaling Genes Dev 2006, 20:399-410. 10.1101/ gad.1394306 16481469
77. Nusse R Wnt signaling in disease and in development Cell Res 2005, 15:28-32. 10.1038/sj.cr.7290260 15686623
78. Willert K Jones KA Wnt signaling: Is the party in the nucleus? Genes Dev 2006, 20:1394-1404. 10.1101/gad.1424006 16751178
79. Sansom OJ Meniel VS Muncan V Phesse TJ Wilkins JA Reed KR Vass JK Athineos D Clevers H Clarke AR Myc deletion rescues Apc deficiency in the small intestine Nature 2007, 446(7136):676-679. 10.1038/nature05674 17377531
80. Zhou BP Deng J Xia W Xu J Li YM Gunduz M Hung MC Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition Nat Cell Biol 2004, 6:931-940. 10.1038/ ncb1173 15448698
81. Cross DA Alessi DR Cohen P Andjelkovich M Hemmings BA Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B Nature 1995, 378(6559):785-789. 10.1038/378785a0 8524413
82. Sears R Nuckolls F Haura E Taya Y Tamai K Nevins JR Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability Genes Dev 2000, 14:2501-2514. 316970 11018017 10.1101/gad.836800
83. McManus EJ Sakamoto K Armit LJ Ronaldson L Shpiro N Marquez R Alessi DR Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis EMBO J 2005, 24:1571-1583. 1142569 15791206 10.1038/sj.emboj.7600633
84. Liu X Rubin JS Kimmel AR Rapid, Wnt-induced changes in GSK3beta associations that regulate beta-catenin stabilization are mediated by Galpha proteins Curr Biol 2005, 15:1989-1997. 10.1016/j.cub.2005.10.050 16303557
85. Boussadia O Kutsch S Hierholzer A Delmas V Kemler R E-cadherin is a survival factor for the lactating mouse mammary gland Mech Dev 2002, 115:53-62. 10.1016/S0925-4773(02)00090-4 12049767
86. Orsulic S Huber O Aberle H Arnold S Kemler R E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation J Cell Sci 1999, 112(Pt 8):1237-1245. 10085258
87. Bergers G Benjamin LE Tumorigenesis and the angiogenic switch Nat Rev Cancer 2003, 3:401-410. 10.1038/nrc1093 12778130
88. St Croix B Rago C Velculescu V Traverso G Romans KE Montgomery E Lal A Riggins GJ Lengauer C Vogelstein B Kinzler KW Genes expressed in human tumor endothelium Science 2000, 289:1197-1202. 10.1126/ science.289.5482.1197 10947988
89. Osaki T Oyama T Gu CD Yamashita T So T Takenoyama M Sugio K Yasumoto K Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage I non-small-cell lung cancer J Clin Oncol 2002, 20:2930-2936. 10.1200/JCO.2002.11.011 12089221
90. Derksen PW Liu X Saridin F van der GH Zevenhoven J Evers B van Beijnum JR Griffioen AW Vink J Krimpenfort P Peterse JL Cardiff RD Berns A Jonkers J Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis Cancer Cell 2006, 10:437-449. 10.1016/ j.ccr.2006.09.013 17097565
91. Giles RH van Es JH Clevers H Caught up in a Wnt storm: Wnt signaling in cancer Biochim Biophys Acta 2003, 1653:1-24. 12781368
92. Morin PJ Sparks AB Korinek V Barker N Clevers H Vogelstein B Kinzler KW Activation of ß-catenin-Tcf signaling in colon cancer by mutations in ß-catenin or APC Science 1997, 275:1787-1790. 10.1126/ science.275.5307.1787 9065402
93. Rubinfeld B Robbins P El Gamil M Albert I Porfiri E Polakis P Stabilization of beta-catenin by genetic defects in melanoma cell lines Science 1997, 275:1790-1792. 10.1126/science.275.5307.1790 9065403
94. Iwao K Nakamori S Kameyama M Imaoka S Kinoshita M Fukui T Ishiguro S Nakamura Y Miyoshi Y Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations Cancer Res 1998, 58:1021-1026. 9500465
95. Sparks AB Morin PJ Vogelstein B Kinzler KW Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer Cancer Res 1998, 58:1130-1134. 9515795
96. Harada N Tamai Y Ishikawa T Sauer B Takaku K Oshima M Taketo MM Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene EMBO J 1999, 18:5931-5942. 1171659 10545105 10.1093/ emboj/18.21.5931
97. Sunaga N Kohno T Kolligs FT Fearon ER Saito R Yokota J Constitutive activation of the Wnt signaling pathway by CTNNB1 (beta-catenin) mutations in a subset of human lung adenocarcinoma Genes Chromosomes Cancer 2001, 30:316-321. 10.1002/ 1098-2264(2000)9999:9999<::AID-GCC1097>3.0.CO;2-9 11170292
98. Mazieres J He B You L Xu Z Jablons DM Wnt signaling in lung cancer Cancer Lett 2005, 222:1-10. 10.1016/j.canlet.2004.08.040 15837535
99. Oda T Kanai Y Oyama T Yoshiura K Shimoyama Y Birchmeier W Sugimura T Hirohashi S E-cadherin gene mutations in human gastric carcinoma cell lines Proc Natl Acad Sci U S A 1994, 91:1858-1862. 43263 8127895 10.1073/ pnas.91.5.1858
100. Zochbauer-Muller S Fong KM Virmani AK Geradts J Gazdar AF Minna JD Aberrant promoter methylation of multiple genes in non-small cell lung cancers Cancer Res 2001, 61:249-255. 11196170
101. Yang J Mani SA Donaher JL Ramaswamy S Itzykson RA Come C Savagner P Gitelman I Richardson A Weinberg RA Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis Cell 2004, 117:927-939. 10.1016/j.cell.2004.06.006 15210113
102. Ma L Teruya-Feldstein J Weinberg RA Tumour invasion and metastasis initiated by microRNA-10b in breast cancer Nature 2007, 449(7163):682-688. 10.1038/nature06174 17898713
103. Huber AH Nelson WJ Weis WI Three-dimensional structure of the armadillo repeat region of beta-catenin Cell 1997, 90:871-882. 10.1016/ S0092-8674(00)80352-9 9298899
104. Huber AH Weis WI The structure of the ß-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by ß-catenin Cell 2001, 105:391-402. 10.1016/S0092-8674(01)00330-0 11348595
105. Hoschuetzky H Aberle H Kemler R Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor J Cell Biol 1994, 127:1375-1380. 2120252 7962096 10.1083/jcb.127.5.1375
106. Shibata T Ochiai A Kanai Y Akimoto S Gotoh M Yasui N Machinami R Hirohashi S Dominant negative inhibition of the association between beta-catenin and c-erbB-2 by N-terminally deleted beta-catenin suppresses the invasion and metastasis of cancer cells Oncogene 1996, 13:883-889. 8806677
107. Ochiai A Akimoto S Kanai Y Shibata T Oyama T Hirohashi S c-erbB-2 gene product associates with catenins in human cancer cells Biochem Biophys Res Commun 1994, 205:73-78. 10.1006/bbrc.1994.2631 7999105
108. Kanai Y Ochiai A Shibata T Oyama T Ushijima S Akimoto S Hirohashi S c-erbB-2 gene product directly associates with beta-catenin and plakoglobin Biochem Biophys Res Commun 1995, 208:1067-1072. 10.1006/ bbrc.1995.1443 7702605
109. Kinch MS Clark GJ Der CJ Burridge K Tyrosine phosphorylation regulates the adhesions of ras-transformed breast epithelia J Cell Biol 1995, 130:461-471. 2199929 7542250 10.1083/jcb.130.2.461
110. Janssen KP Alberici P Fsihi H Gaspar C Breukel C Franken P Rosty C Abal M El Marjou F Smits R Louvard D Fodde R Robine S APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression Gastroenterology 2006, 131:1096-1109. 10.1053/ j.gastro.2006.08.011 17030180
111. Behrens J Vakaet L Friis R Winterhager E Van Roy F Mareel MM Birchmeier W Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene J Cell Biol 1993, 120:757-766. 2119534 8425900 10.1083/jcb.120.3.757
112. Roura S Miravet S Piedra J Garcia H Dunach M Regulation of E-cadherin/ Catenin association by tyrosine phosphorylation J Biol Chem 1999, 274:36734-36740. 10.1074/jbc.274.51.36734 10593980
113. Piedra J Martinez D Castano J Miravet S Dunach M de Herreros AG Regulation of beta-catenin structure and activity by tyrosine phosphorylation J Biol Chem 2001, 276:20436-20443. 10.1074/ jbc.M100194200 11279024
114. Coluccia AM Benati D Dekhil H De Filippo A Lan C Gambacorti-Passerini C SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling Cancer Res 2006, 66:2279-2286. 10.1158/0008-5472.CAN-05-2057 16489032
115. Rosato R Veltmaat JM Groffen J Heisterkamp N Involvement of the tyrosine kinase fer in cell adhesion Mol Cell Biol 1998, 18:5762-5770. 109162 9742093
116. Ozawa M Kemler R Altered cell adhesion activity by pervanadate due to the dissociation of alpha-catenin from the E-cadherin.catenin complex J Biol Chem 1998, 273:6166-6170. 10.1074/jbc.273.11.6166 9497337
117. Brembeck FH Schwarz-Romond T Bakkers J Wilhelm S Hammerschmidt M Birchmeier W Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions Genes Dev 2004, 18:2225-2230. 517514 15371335 10.1101/gad.317604
118. Monga SP Mars WM Pediaditakis P Bell A Mule K Bowen WC Wang X Zarnegar R Michalopoulos GK Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes Cancer Res 2002, 62:2064-2071. 1821077 11929826
119. Hiscox S Jiang WG Association of the HGF/SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells Biochem Biophys Res Commun 1999, 261:406-411. 10.1006/ bbrc.1999.1002 10425198
120. Reshetnikova G Troyanovsky S Rimm DL Definition of a direct extracellular interaction between Met and E-cadherin Cell Biol Int 2007, 31:366-373. 10.1016/j.cellbi.2007.01.022 17336101
121. Nakamura Y Niki T Goto A Morikawa T Miyazawa K Nakajima J Fukayama M c-Met activation in lung adenocarcinoma tissues: An immunohistochemical analysis Cancer Sci 2007, 98:1006-1013. 10.1111/j.1349-7006.2007.00493.x 17459054
122. Kong-Beltran M Seshagiri S Zha J Zhu W Bhawe K Mendoza N Holcomb T Pujara K Stinson J Fu L Severin C Rangell L Schwall R Amler L Wickramasinghe D Yauch R Somatic mutations lead to an oncogenic deletion of met in lung cancer Cancer Res 2006, 66:283-289. 10.1158/ 0008-5472.CAN-05-2749 16397241
123. Gottardi CJ Gumbiner BM Distinct molecular forms of beta-catenin are targeted to adhesive or transcriptional complexes J Cell Biol 2004, 167:339-349. 2172558 15492040 10.1083/jcb.200402153
124. Nguyen DX Massague J Genetic determinants of cancer metastasis Nat Rev Genet 2007, 8:341-352. 10.1038/nrg2101 17440531
125. Cavallaro U Christofori G Cell adhesion and signalling by cadherins and Ig-CAMs in cancer Nat Rev Cancer 2004, 4:118-132. 14964308
126. Slack JM Metaplasia and transdifferentiation: From pure biology to the clinic Nat Rev Mol Cell Biol 2007, 8:369-378. 10.1038/nrm2146 17377526
127. Strahl BD Allis CD The language of covalent histone modifications Nature. 2000, 403(6765):41-45. 10.1038/47412 10638745
128. Sparmann A van Lohuizen M Polycomb silencers control cell fate, development and cancer Nat Rev Cancer 2006, 6:846-856. 10.1038/nrc1991 17060944
129. Schuettengruber B Chourrout D Vervoort M Leblanc B Cavalli G Genome regulation by polycomb and trithorax proteins Cell 2007, 128:735-745. 10.1016/j.cell.2007.02.009 17320510
130. Rossant J Stem cells: The magic brew Nature 2007, 448(7151):260-262. 10.1038/448260a 17637646
131. Takahashi K Yamanaka S Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 2006, 126:663-676. 10.1016/j.cell.2006.07.024 16904174
132. Okita K Ichisaka T Yamanaka S Generation of germline-competent induced pluripotent stem cells Nature 2007, 448(7151):313-317. 10.1038/ nature05934 17554338
133. Wernig M Meissner A Foreman R Brambrink T Ku M Hochedlinger K Bernstein BE Jaenisch R In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state Nature 2007, 448(7151):318-324. 10.1038/nature05944 17554336
134. Maherali N Sridharan R Xie W Utikal J Eminli S Arnold K Stadtfeld M Yachechko R Tchieu J Jaenisch R Plath K Hochedlinger K Directly Reprogrammed Fibroblasts Show Global Epigenetic Remodeling and Widespread Tissue Contribution Cell Stem Cell 2007, 1:55-70. 10.1016/ j.stem.2007.05.014 18371336
135. Park IH Zhao R West JA Yabuuchi A Huo H Ince TA Lerou PH Lensch MW Daley GQ Reprogramming of human somatic cells to pluripotency with defined factors Nature (London) 2007.
136. Nakagawa M Koyanagi M Tanabe K Takahashi K Ichisaka T Aoi T Okita K Mochiduki Y Takizawa N Yamanaka S Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts Nat Biotechnol 2008, 26:101-106. 10.1038/nbt1374 18059259
137. Adhikary S Eilers M Transcriptional regulation and transformation by Myc proteins Nat Rev Mol Cell Biol 2005, 6:635-645. 10.1038/nrm1703 16064138
138. Arnold HK Sears RC A tumor suppressor role for PP2A-B56alpha through negative regulation of c-Myc and other key oncoproteins Cancer Metastasis Rev 2008. 18246411
139. Ehrhardt A Bartels T Geick A Klocke R Paul D Halter R Development of pulmonary bronchiolo-alveolar adenocarcinomas in transgenic mice overexpressing murine c-myc and epidermal growth factor in alveolar type II pneumocytes. Br J Cancer 2001, 84:813-818. 10.1054/bjoc.2000.1676 11259097
140. Felsher DW Bishop JM Reversible tumorigenesis by MYC in hematopoietic lineages Molecular Cell 1999, 4:199-207. 10.1016/S1097-2765(00)80367-6 10488335
141. Shachaf CM Kopelman AM Arvanitis C Karlsson A Beer S Mandl S Bachmann MH Borowsky AD Ruebner B Cardiff RD Yang Q Bishop JM Contag CH Felsher DW
142. Dang CV O'Donnell KA Zeller KI Nguyen T Osthus RC Li F The c-Myc target gene network Semin Cancer Biol 2006, 16:253-264. 10.1016/ j.semcancer.2006.07.014 16904903
143. Bieda M Xu X Singer MA Green R Farnham PJ Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome Genome Res 2006, 16:595-605. 1457046 16606705 10.1101/gr.4887606
144. Dominguez-Sola D Ying CY Grandori C Ruggiero L Chen B Li M Galloway DA Gu W Gautier J Dalla-Favera R Non-transcriptional control of DNA replication by c-Myc Nature 2007, 448(7152):445-451. 10.1038/nature05953 17597761
145. Okubo T Hogan BL Hyperactive Wnt signaling changes the developmental potential of embryonic lung endoderm J Biol 2004, 3:11. 469027 15186480 10.1186/jbiol3
146. Baba Y Garrett KP Kincade PW Constitutively active beta-catenin confers multilineage differentiation potential on lymphoid and myeloid progenitors Immunity 2005, 23:599-609. 1850237 16356858 10.1016/ j.immuni.2005.10.009
147. Prehn RT The role of mutation in the new cancer paradigm Cancer Cell Int 2005, 5:9. 1090602 15854226 10.1186/1475-2867-5-9
148. Rapp UR Ceteci F Schreck R Oncogene-induced plasticity and cancer stem cells Cell Cycle 2007, 7:45-51. 18196970
149. Reya T Duncan AW Ailles L Domen J Scherer DC Willert K Hintz L Nusse R Weissman IL A role for Wnt signalling in self-renewal of haematopoietic stem cells Nature (London) 2003, 423:409-414. 10.1038/nature01593
150. Kirstetter P Anderson K Porse BT Jacobsen SE Nerlov C Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block Nat Immunol 2006, 7:1048-1056. 10.1038/ni1381 16951689
151. Scheller M Huelsken J Rosenbauer F Taketo MM Birchmeier W Tenen DG Leutz A Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation Nat Immunol 2006, 7:1037-1047. 10.1038/ni1387 16951686